Theodoros Karantanos

Dr. Theodoros Karantanos has contributed extensively to the field of oncology, with a particular focus on the molecular biology of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML). As an Assistant Professor of Oncology at Johns Hopkins Medicine, he is dedicated to advancing our understanding of these complex hematological disorders. His research aims to unravel the molecular mechanisms underlying MDS and AML, with the goal of developing more effective therapeutic strategies. Dr. Karantanos's expertise in acute leukemia and myelodysplastic syndromes is complemented by his active involvement in several prestigious professional organizations. He is a valued member of the American Society of Hematology and the American Society of Clinical Oncology, where he collaborates with fellow experts to push the boundaries of cancer research and treatment. His work is characterized by a commitment to translating scientific discoveries into clinical applications that improve patient outcomes. In addition to his research endeavors, Dr. Karantanos is passionate about mentoring the next generation of oncologists and researchers. He is known for his engaging teaching style and his ability to inspire students and colleagues alike. Through his contributions to both research and education, Dr. Karantanos continues to make a significant impact on the field of oncology, striving to enhance the lives of patients affected by hematological malignancies.